Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Karpus Management, Inc. NEA Nuveen AMT-Free Quality Municipal Income Fund 13D/A 5.23% 2y
Blackhurst Don PNBK Patriot National Bancorp Inc 13D 6.5% 2y
SUVRETTA CAPITAL MANAGEMENT, LLC BNTC Benitec Biopharma Inc. 13D/A 49.9% 2y
TANG CAPITAL MANAGEMENT LLC ITOS iTeos Therapeutics, Inc. Common Stock 13G 6.6% 2y
Liao Yu CHSN Chanson International Holding 13G 3.1% 2y
Minzhu Xu CHSN Chanson International Holding 13G 3.9% 2y
Xiaodi Han CHSN Chanson International Holding 13G 6.3% 2y
Yuan Yang CHSN Chanson International Holding 13G 3.1% 2y
Apeiron Investment Group Ltd. RZLV Rezolve Ai PLC 13G 10.4% 2y
VIKING GLOBAL INVESTORS LP BMRN Biomarin Pharmaceutical Inc 13G 5.1% 2y
M3 Funds, LLC NODK NI Holdings, Inc. 13G 5.31% 2y
MILLENNIUM MANAGEMENT LLC AMCX AMC Global Media Inc. 13G 4.8% 2y
Madison Avenue Partners, LP WLY John Wiley & Sons, Inc. 13G 5.1% 2y
SPENCE LIMITED, LP EWSB EWSB Bancorp, Inc. 13G 7.97% 2y
Saudi Economic and Development Securities Company VERO Venus Concept Inc. 13G/A 3.5% 2y
THRC Holdings, LP ACDC ProFrac Holding Corp. 13D/A 49.5% 2y
HAWK RIDGE CAPITAL MANAGEMENT LP APPN Appian Corp 13G/A 4.9% 2y
Jacobsen Per A. MTEK Maris Tech Ltd. 13G 5.16% 2y
BROOKFIELD Corp /ON/ BBUC Brookfield Business Corp 13D/A 64.8% 2y
Saba Capital Management, L.P. CEV Eaton Vance California Municipal Income Trust 13D/A 11.44% 2y
MASAYA OTSUKA XPON Expion Energy, Inc. 13G/A 0% 2y
BROOKFIELD Corp /ON/ BBUC Brookfield Business Corp 13D/A 65.7% 2y
GAMCO INVESTORS, INC. ET AL SSP E.W. SCRIPPS Co 13D/A 4.09% 2y
ATAI Life Sciences N.V. CMPS COMPASS Pathways plc 13D/A 10.1% 2y
ICAHN CARL C IEP Icahn Enterprises L.P. 13D/A 86.24% 2y
Timothy A. Springer RNAC Cartesian Therapeutics, Inc. 13D/A 36.7% 2y
Fund 1 Investments, LLC CTRN Citi Trends Inc 13D/A 29.9% 2y
AECOM SHIM Shimmick Corp 13D/A 19.9% 2y
BARD ASSOCIATES INC NCPL Netcapital Inc. 13G/A 0.4% 2y
ARES MANAGEMENT LLC OUT OUTFRONT Media Inc. 13D/A 0% 2y
Ma Jingjing CHSN Chanson International Holding 13G/A 7.8% 2y
Wei Xiushen CHSN Chanson International Holding 13G/A 9.9% 2y
Scablis AG ONCO Onconetix, Inc. 13G 7% 2y
Kong Yong CHSN Chanson International Holding 13G/A 12.2% 2y
ROBOTTI ROBERT FPH Five Point Holdings, LLC 13D 9.7% 2y
Zhou Yingjia CHSN Chanson International Holding 13G/A 10% 2y
Wang Gehuang CHSN Chanson International Holding 13G/A 11.2% 2y
JANA Partners Management, LP RPD Rapid7, Inc. 13D 5.8% 2y
Tony L. Alford LCU Lion Copper Corp. 13D/A 40.5% 2y
TCG Crossover GP II, LLC THRD Third Harmonic Bio, Inc. Common Stock 13G 5.9% 2y
Radoff Bradley Louis NURO NeuroMetrix, Inc. Common Stock 13G 7.5% 2y
BOXER CAPITAL, LLC TIL Instil Bio, Inc. 13G 5.5% 2y
GLAZER CAPITAL, LLC ITI Iteris, Inc. 13G 6.61% 2y
PERCEPTIVE ADVISORS LLC TIL Instil Bio, Inc. 13G 5.3% 2y
Jinyu Chang HTCO High-Trend International Group 13D/A 0.78% 2y
De Lisle Partners LLP MNTX Manitex International, Inc. 13G 5.5% 2y
GKCC, LLC XLO Xilio Therapeutics, Inc. 13G 15.9% 2y
TANG CAPITAL MANAGEMENT, LLC OKUR OnKure Therapeutics, Inc. 13G 8.8% 2y
Samvardhana Motherson International Ltd. REEAF REE Automotive Ltd. 13D 19.6% 2y
GAMCO INVESTORS, INC. ET AL TSAT Telesat Corp 13D/A 13.91% 2y